Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma (Unknown)
- New search for: Wang, Yujiao
- New search for: Zhang, XinXing
- New search for: Dai, Xiaosong
- New search for: He, Dingxiu
- New search for: Wang, Yujiao
- New search for: Zhang, XinXing
- New search for: Dai, Xiaosong
- New search for: He, Dingxiu
In:
Expert Review of Anticancer Therapy
;
21
, 10
;
1161-1170
;
2021
- Article (Journal) / Electronic Resource
-
Title:Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma
-
Contributors:Wang, Yujiao ( author ) / Zhang, XinXing ( author ) / Dai, Xiaosong ( author ) / He, Dingxiu ( author )
-
Published in:Expert Review of Anticancer Therapy ; 21, 10 ; 1161-1170
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2021-10-03
-
Size:10 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 21, Issue 10
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1067
-
How will artificial intelligence impact breast cancer research efficiency?Franceschini, Gianluca / Mason, Elena Jane / Orlandi, Armando / D’Archi, Sabatino / Sanchez, Alejandro Martin / Masetti, Riccardo et al. | 2021
- 1071
-
The safety and efficacy of erlotinib and ramucirumab combination in EGFR-mutant non-small-cell lung cancerBoussageon, Maxime / Swalduz, Aurélie / Pérol, Maurice et al. | 2021
- 1081
-
Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacyHenriques-Abreu, Miguel / Serrano, César et al. | 2021
- 1089
-
Real-world experience with trabectedin for the treatment of recurrent ovarian cancerRomero, Ignacio / López-Guerrero, José Antonio / Pignata, Sandro et al. | 2021
- 1097
-
Heterogeneous clinical and pathological landscapes of HER2 positive colorectal cancerChen, Zhiqin / Chen, Jinde / Gao, Yong / Quan, Ming et al. | 2021
- 1105
-
The evolution of cyclin dependent kinase inhibitors in the treatment of cancerJhaveri, Komal / Burris 3rd, Howard A / Yap, Timothy A / Hamilton, Erika / Rugo, Hope S / Goldman, Jonathan W / Dann, Stephen / Liu, Feng / Wong, Gilbert Y / Krupka, Heike et al. | 2021
- 1125
-
Factors associated with early lung cancer mortality: a systematic reviewGoussault, Helene / Gendarme, Sebastien / Assié, Jean Baptiste / Bylicki, Olivier / Chouaïd, Christos et al. | 2021
- 1135
-
New prophylaxis strategies to reduce the risk of thromboembolism in cancerPapadopoulos, Vasileios / Tsapakidis, Konstantinos / Markou, Alexandra / Kokkalis, Alexandros / Aidarinis, Chrissovalantis / Kotsakis, Athanasios et al. | 2021
- 1145
-
Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensityShayne, Michelle / Harvey, R. Donald / Lyman, Gary H. et al. | 2021
- 1161
-
Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinomaWang, Yujiao / Zhang, XinXing / Dai, Xiaosong / He, Dingxiu et al. | 2021
- 1171
-
A new prognostic model for predicting 30-day mortality in acute oncology patientsO’Neill, Tess / Hudda, Mohammed T / Patel, Reena / Liu, Wing Kin / Young, Anna-Mary / Patel, Hitendra RH / Afshar, Mehran et al. | 2021